0.5950
+0.0550
+(10.19%)
At close: February 18 at 3:29:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
21,082.0000
-19,122.0000
-99,964.0000
-125,609.0000
-35,387.0000
Investing Cash Flow
16,252.0000
28,087.0000
137,590.0000
-76,903.0000
-93,534.0000
Financing Cash Flow
-23,780.0000
-29,143.0000
70,575.0000
1,589.0000
357,860.0000
End Cash Position
182,893.0000
140,324.0000
161,705.0000
56,304.0000
256,794.0000
Capital Expenditure
-962.0000
-2,480.0000
-18,438.0000
-14,202.0000
-603.0000
Issuance of Capital Stock
--
-354.0000
-753.0000
-8,115.0000
367,726.0000
Issuance of Debt
15,566.0000
11,426.0000
77,491.0000
12,040.0000
--
Repayment of Debt
-34,748.0000
-35,211.0000
-1,352.0000
--
--
Free Cash Flow
20,120.0000
-21,602.0000
-118,402.0000
-139,811.0000
-35,990.0000
12/31/2020 - 2/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHPN.F Galectin Therapeutics Inc.
1.4200
+10.08%
CRO.DU hVIVO PLC
0.1920
0.00%
CRO.BE Open Orphan PLC
0.2120
0.00%
OPORF hVIVO plc
0.2400
-31.43%
CRO.F hVIVO plc
0.1860
-19.83%
HPHA.F Heidelberg Pharma AG
2.2900
-0.87%
EU6.F PDS Biotechnology Corporation
1.4950
+0.47%
AYJ.DE Valneva SE
3.5520
+5.28%
J90.F NurExone Biologic Inc.
0.3920
0.00%
ALTME.PA TME Pharma N.V.
0.0755
-2.20%